secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2025-07-22T23:59:59+00:00
Accession:  0000896264-25-000178
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q2: net sales +11% to $236M, net earnings -7%; FY guidance reiterated
---------------------------------------------------------------------------

- Net sales $236M (+11% YoY); net earnings $9.7M (-7% YoY); diluted EPS $0.52 (-4% YoY).
- Adjusted diluted EPS $0.74 (+36% YoY); adjusted EBITDA $30.5M (+13% YoY).
- Direct selling Active Customers fell 11% YoY to 418k; Hiya subscribers 200.4k.
- Repurchased 528k shares for $15M; ended quarter debt-free with $151M cash.
- Reiterated FY2025 outlook: net sales $920M-$1.0B, adjusted EPS $2.35-$3.00.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000178/0000896264-25-000178-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000178/usna-20250722.htm
  HTML page:      https://secwatch.observer/filing/0000896264-25-000178

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer